[ad_1]
"60 Million Consumers" warn about the risks of taking sleeping pills. – GILE / SIPA
The sleeping pills containing benzodiazepines could be accompanied by several types of worrying side effects, reveals a survey published this Thursday in the special issue "Good sleep, how to use" of 60 Million Consumers. These prescription drugs, especially those marketed under the names of Zolpidem, Stilnox or Imovane, were used by one in eight French people during the year.
Sleeping pills, melatonin … Some medicines for better sleep can have undesirable effects: fast addiction, sedative effect, vertigo … @ 60 million investigated. #sleeping tablets #health # melatonin https://t.co/Jenf6UEf3K
– 60 million (@ 60million) November 8, 2018
The authors of the article argue that it only takes a month to become dependent on the substance, with a weaning that can take up to a year. During this time, patients may experience sleep problems but may also have headaches or anxiety. As for users who increase the dosage following the adaptation of the body to the treatment, they may increase the intensity of the side effects cited by the authors of the survey: "sleepiness, difficulty of attention or memory, state confusional, falls … ".
Many microreveils
The magazine also highlights the poor quality of sleep of benzodiazepine followers, who think well sleep while they actually know many microreveils. Various studies have shown that the latter have the potential consequences of an increase in the risk of cancer but also of aggression towards others or oneself. An badociation with the evolution of Alzheimer's disease has also been mentioned. All for an action that some scientists do not hesitate to question.
The opinion of 60 million consumers on other types of sleeping pills is not more rebaduring. The
Over-the-counter antihistamine medications for a few days may cause dizziness and cognitive impairment due to their prolonged sedative effect. Melatonin, it would have a confirmed beneficial effect only on subjects over 55 years and during a short term. In April this year, the health authorities also
not recommended for certain populations.
[ad_2]
Source link
